RASSF8 downregulation promoted ESCC metastasis by enhancing cell motility and invasiveness and by increasing lymphangiogenesis via the NF-κB/VEGF-C axis. The gene discussed is NFKB1; the disease is esophageal squamous cell carcinoma.